Highlights and Quick Summary
- Debt/Assets for the quarter ending September 30, 2023 was 7.13% (a -21.3% decrease compared to previous quarter)
- Year-over-year quarterly Debt/Assets increased by 6.9%
- Annual Debt/Assets for 2022 was 6.67% (a 93.33% increase from previous year)
- Annual Debt/Assets for 2021 was 3.45% (a Infinity% increase from previous year)
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Debt/Assets of Prime Medicine, Inc.
Most recent Debt/Assetsof PRME including historical data for past 10 years.Interactive Chart of Debt/Assets of Prime Medicine, Inc.
Prime Medicine, Inc. Debt/Assets for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 7.13% | 9.06% | 8.19% | – | – |
| 2022 | 6.67% | 14.6% | 0.0% | 0.0% | 6.67% |
| 2021 | – | – | 0.0% | 0.0% | 3.45% |
| 2020 | 0.0% | – | – | – | 0.0% |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology